Drugs / Group B streptococcus (GBS) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01150123 | May 2010 → Nov 2011 | group B streptococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group B streptococcus (GBS) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01150123 ↗ |
| Modality | Vaccine | “This study evaluates two different dosages, two injection schedules and three formulations of an investigational trivalent (serotypes Ia, Ib and III) CRM197-glycoconjugate GBS...” PMID 26928074 ↗ Mar 2016 |